PTC Therapeutics to Participate at Upcoming Investor Conference PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conference: SVB Securities...
Thursday, February 2, 2023 1 min read
Key Takeaway: PTC Therapeutics, Inc. announced its participation in the SVB Securities Global Biopharma Conference on February 14, 2023. The company will provide a company overview during the event, which will also be accessible via a live webcast. This move is expected to broaden investor engagement and showcase its developments in the biopharma sector.
Market Sentiment Analysis
POSITIVE FACTORS
PTC Therapeutics is participating in a prominent investor conference.
The company is providing a live webcast for broader accessibility.
The presentation might enhance visibility and interest among investors.
Full Press Release Details
SOUTH PLAINFIELD, N.J. , Feb. 2, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that the company will present a company overview at the following conference:
SVB Securities Global Biopharma Conference Tuesday, Feb. 14 at 9:20 a.m. EST
The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.